Day: September 19, 2019

AIM ImmunoTech Inc. Announces the U.S. Department of Defense’s Award of $6.42M to Roswell Park Comprehensive Cancer Center to Study Ampligen as Part of a New Treatment of Brain-Metastatic Breast Cancer

Viseon, Inc. Announces US FDA Clearance and Clinical Use of its Advanced High-Definition Real Time Imaging Technology for Minimally Invasive Spine Surgery

IRVINE, Calif.--(BUSINESS WIRE)--Viseon, Inc. today announced US FDA clearance and initial clinical use of their Voyant System, integrating minimally invasive...

error: Content is protected !!